Pfizer: Former Schering-Plough Products Added

decrease font size

increase font size

change type face

bookmark this page

email this page

print this page

Latest Pig Industry News

Thursday, September 11, 2008

Print This Page

Pfizer: Former Schering-Plough Products Added

FRANCE - Pfizer Animal Health has announced that its acquisition of multiple product franchises in Europe from the Schering-Plough Corporation has been completed and approved by the European Commission. Pfizer has acquired these assets for approximately â‚¬116 million in cash.

The acquisition adds both biological and pharmaceutical products across the major animal health species including cattle, swine, equine and companion animal to Pfizerâ€™s portfolio. Pfizer has acquired certain rights to the following products in the European Economic Area:

The Gletvax range of swine E.coli vaccines

The Equip range of equine Influenza and Tetanus vaccines

The Covexin range of ruminant Clostridial vaccines

Lactovac -C, a cattle neonatal vaccine

Rabdomun, a Rabies vaccine

Companion animal specialist products Insuvet and Eutha 77

The Autoworm range of parasiticides, Coopers Spot-On in the UK, Coopers Spot-on CY in Ireland and Versatrine in France

Quadrisol 100, anti-inflammatory product

"This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners,â€ said Albert Bourla, Pfizer Animal Healthâ€™s area president, Europe, Africa, Middle East.

"Pfizer now has the most in-depth coverage of therapeutic areas in Europe, and the most highly recognized brands in the industry," Mr Bourla said.

ThePigSite News Desk

Read more Pfizer Animal Health News here